Dr William Lee Johnson, MD | |
1102 Saint Marys Rd, Junction City, KS 66441-4139 | |
(785) 210-3356 | |
Not Available |
Full Name | Dr William Lee Johnson |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 1102 Saint Marys Rd, Junction City, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326295387 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr William Lee Johnson, MD 1102 Saint Marys Rd, Junction City, KS 66441-4139 Ph: (785) 210-3356 | Dr William Lee Johnson, MD 1102 Saint Marys Rd, Junction City, KS 66441-4139 Ph: (785) 210-3356 |
News Archive
iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak's device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers.
A moderate level of aerobic fitness can significantly reduce stroke risk for men and women, according to a large, long-running study presented at the American Stroke Association's International Stroke Conference 2008.
Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world.
Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
› Verified 7 days ago